Pharmacogenomics-informed clozapine therapy

Lancet Psychiatry. 2023 Mar;10(3):160-162. doi: 10.1016/S2215-0366(23)00032-9.

Author

Chad A Bousman¹

Affiliation

¹ Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, Cumming School of Medicine and Department of Medical Genetics and Department of Psychiatry and Department of Physiology and Pharmacology and Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada; Alberta Children's Hospital Research Institute, Calgary, AB, Canada. Electronic address: [email protected].

PMID: 36804063
DOI: 10.1016/S2215-0366(23)00032-9

No abstract available

Publication types

Comment

MeSH terms

Antipsychotic Agents* / therapeutic use
Clozapine* / therapeutic use
Humans
Pharmacogenetics
Schizophrenia* / drug therapy
Schizophrenia* / genetics

Substances

Clozapine
Antipsychotic Agents